Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
+0.080 (5.80%)
At close: Jul 23, 2024, 4:00 PM
-0.020 (-1.37%)
After-hours: Jul 23, 2024, 6:23 PM EDT

Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $306.01 million. The enterprise value is $298.69 million.

Market Cap 306.01M
Enterprise Value 298.69M

Important Dates

The next estimated earnings date is Friday, August 23, 2024, before market open.

Earnings Date Aug 23, 2024
Ex-Dividend Date n/a

Share Statistics

AKBA has 209.60 million shares outstanding. The number of shares has increased by 10.93% in one year.

Shares Outstanding 209.60M
Shares Change (YoY) +10.93%
Shares Change (QoQ) +7.91%
Owned by Insiders (%) 2.14%
Owned by Institutions (%) 27.01%
Float 203.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.62
Forward PS 1.58
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.60
EV / EBITDA 40.68
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.70

Current Ratio 1.70
Quick Ratio 1.03
Debt / Equity n/a
Debt / EBITDA 5.15
Debt / FCF n/a
Interest Coverage -5.18

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -18.00%
Return on Capital (ROIC) -300.73%
Revenue Per Employee $1.12M
Profits Per Employee -$257,677
Employee Count 167
Asset Turnover 0.78
Inventory Turnover 2.84


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +19.67% in the last 52 weeks. The beta is 0.77, so AKBA's price volatility has been lower than the market average.

Beta (5Y) 0.77
52-Week Price Change +19.67%
50-Day Moving Average 1.12
200-Day Moving Average 1.28
Relative Strength Index (RSI) 71.99
Average Volume (20 Days) 4,439,961

Short Selling Information

The latest short interest is 13.11 million, so 6.26% of the outstanding shares have been sold short.

Short Interest 13.11M
Short Previous Month 12.30M
Short % of Shares Out 6.26%
Short % of Float 6.43%
Short Ratio (days to cover) 3.40

Income Statement

In the last 12 months, AKBA had revenue of $187.23 million and -$43.03 million in losses. Loss per share was -$0.23.

Revenue 187.23M
Gross Profit 121.66M
Operating Income -31.65M
Pretax Income -43.03M
Net Income -43.03M
EBIT -36.06M
Loss Per Share -$0.23
Full Income Statement

Balance Sheet

The company has $41.96 million in cash and $37.78 million in debt, giving a net cash position of $4.18 million or $0.02 per share.

Cash & Cash Equivalents 41.96M
Total Debt 37.78M
Net Cash 4.18M
Net Cash Per Share $0.02
Equity (Book Value) -27.26M
Book Value Per Share -0.13
Working Capital 46.46M
Full Balance Sheet

Cash Flow

Operating Cash Flow -25.28M
Capital Expenditures n/a
Free Cash Flow -25.28M
FCF Per Share -$0.12
Full Cash Flow Statement


Gross margin is 64.98%, with operating and profit margins of -16.90% and -22.98%.

Gross Margin 64.98%
Operating Margin -16.90%
Pretax Margin -22.98%
Profit Margin -22.98%
EBITDA Margin 3.92%
EBIT Margin -19.26%
FCF Margin -13.50%

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.93%
Shareholder Yield -10.93%
Earnings Yield -14.21%
FCF Yield -8.35%

Analyst Forecast

The average price target for AKBA is $5.00, which is 242.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.00
Price Target Difference 242.47%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 18.40%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


AKBA has an Altman Z-Score of -8.83 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.83
Piotroski F-Score 4